Clinical Trial Update: Oxaliplatin With or Without Gefitinib in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating oxaliplatin with or without gefitinib in patients with metastatic or locally recurrent colorectal cancer has completed Phase 1/2 tes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• Iressa (gefitinib)

Snippet

Sponsor: University of Chicago | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED